Nav: Home

Black-white cancer mortality gap nearly eliminated in some age groups

February 14, 2019

Although African Americans still bear a disproportionate share of the cancer burden, a new report finds the black-white gap has closed considerably over the past several decades. Cancer Statistics for African Americans and its companion publication Cancer Facts & Figures for African Americans, published every three years by American Cancer Society investigators, reports that the overall cancer death rate is dropping faster in blacks than in whites, largely driven by greater declines for three of the four most common cancers.

The report appears early online in CA: A Cancer Journal for Clinicians, a peer-reviewed journal of the American Cancer Society.

The black-white disparity is narrowing for lung, prostate, and colorectal cancer and has stabilized since 2010 for breast cancer. As a result, the excess risk of overall cancer death in blacks compared with whites dropped from 47% in 1990 to 19% in 2016 in men and from 19% to 13% in women. Progress is even greater in men under 50 and women 70 and over, among whom the black-white cancer disparity has been nearly eliminated.

Despite the declining disparity, African Americans have the highest death rate and the lowest survival rate of any racial or ethnic group for most cancers in the United States. Socioeconomic status (SES), which is strongly correlated with race in this country, is the most critical factor driving these racial inequalities.

To monitor progress in reducing those inequalities, every three years the American Cancer Society provides the most recent data on cancer incidence, mortality, survival, screening, and risk factors, as well as the estimated numbers of new cancer cases and deaths in the current year, using data from the National Cancer Institute, the North American Association of Central Cancer Registries, and the National Center for Health Statistics.

In 2019, approximately 202,260 new cancer cases and 73,030 cancer deaths are expected to occur among blacks in the United States. Prostate cancer is the most commonly diagnosed cancer in black men, and breast cancer is the most commonly diagnosed in black women, each accounting for nearly one-third of cancers diagnosed in each sex. Cancers of the lung and colorectum are the second and third most common cancers, respectively, in both black men and women.

During 2006 through 2015, the overall cancer incidence rate also decreased faster in black men than in white men (2.4% vs 1.7% per year), largely due to more rapid declines in lung cancer. The incidence rate was stable in black women (compared with a slight increase in white women), reflecting increasing rates for breast, endometrial, and pancreatic cancer offsetting by declining trends for lung and colorectal cancer.

Lung cancer is the leading cause of cancer death among both men (25% of deaths) and women (20% of deaths), followed by breast cancer in women (18%) and prostate cancer in men (15%). Colorectal cancer is expected to be the third-leading cause of cancer death for black men and women.

Overall cancer death rates were lower in blacks than in whites during the early 1950s; however, rates increased sharply in blacks from 1950 through 1990 and have remained higher compared with whites since the 1960s. Cancer death rates peaked in black men and women in the early 1990s and have subsequently declined, with a steeper decline in men. That progress translates into the avoidance of more than 462,000 cancer deaths over the past 25 years.

The narrowing of black-white disparities is striking in some age groups. Among men ages 40 to 49, the cancer death rate was 102% higher in blacks than in whites during 1990-1991 but had shrunk to just 17% higher during 2015-2016. Among women ages 40 to 49, the overall disparity narrowed from 44% in 1990-1991 to 30% in 2015-2016. And among black women ages 80 to 89, the cancer mortality rate was 8% higher than whites during 2002-2003, but 3% lower in 2015-2016.

"Seeing the substantial progress made over the past several decades in reducing black-white disparities in cancer mortality is incredibly gratifying," said Len Lichtenfeld, M.D., interim chief medical officer for the American Cancer Society. "This progress is driven in large part by drops in the lung cancer death rate driven by more rapid decreases in smoking over the past 40 years in blacks than in whites. To continue this progress, we need to expand access to high-quality cancer prevention, early detection, and treatment for all Americans."
Article: Cancer Statistics for African Americans, 2019, CA Cancer J Clin 2019; doi: 10.3322/caac.21555.

URL upon publication:

American Cancer Society

Related Breast Cancer Articles:

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.
Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
More Breast Cancer News and Breast Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at